CapitalOne initiated coverage on Repare Therapeutics with a new price target
$RPTX
Biotechnology: Pharmaceutical Preparations
Health Care
CapitalOne initiated coverage of Repare Therapeutics with a rating of Overweight and set a new price target of $28.00